期刊文献+

胰岛素泵联合吡格列酮治疗初诊2型糖尿病的临床观察 被引量:5

下载PDF
导出
摘要 目的评价胰岛素泵联合吡格列酮治疗初诊2型糖尿病的临床疗效。方法34例初诊2型糖尿病患者随机分为胰岛素泵治疗(CSⅡ)和CSⅡ合用吡格列酮组强化治疗2~4周。结果发现CSⅡ合用吡格列酮胰岛素用量减少(P〈0.01),HoMA-IR下降(P〈0.05),且无严重低血糖反应,肝肾功能损害等副作用。结论CSⅡ合用吡格列酮治疗初发2型糖尿病更能有效的控制血糖,减轻胰岛素抵抗和改善胰岛B细胞功能。
作者 窦念涛
出处 《安徽医药》 CAS 2009年第6期665-666,共2页 Anhui Medical and Pharmaceutical Journal
  • 相关文献

参考文献9

二级参考文献39

  • 1李光伟,宁光,周智广.2型糖尿病早期胰岛素强化治疗改善胰岛β细胞功能——是现实还是梦想?[J].中华内分泌代谢杂志,2006,22(4):309-312. 被引量:223
  • 2Weyer. Dificiency in AIR predict IGT and Type 2 diabetes. Diabetes Care, 2001,24 : 89-94.
  • 3Haffner SM, Miettinen H, Gaskill SP, et al. Decreased insulin secretion and increased insulin resistance are independently related to the 7-year risk of NIDDM in Mexican-Americans. Diabetes, 1995,44: 1386-1391.
  • 4Bruce DG, Chisholm DJ, Leonare H, et al. Physiological importance of deficiency in early prandial insulin secretion in non-in-sulin-dependent diabetes. Diabetes, 1988,37: 736-743.
  • 5Bruttomesso D, Pianta A, Mari A, et al. Restoration of early rise in plasma insulin levels improves the glucose tolerance of type 2 diabetic patients. Diabetes, 1999,48: 99-105.
  • 6Ilkova H, glaser B, Tunckale A, et al. Induction of long-term glycemic control in newly diagnosed type 2 diabetic patients by transient intensive insulin treatment. Diabetes Care, 1997,20:1353-1356.
  • 7Walton C, Godsland IF, Proudler AJ, et al. Effect of body mass index and fat distribution on insulin sensitivity, secretion, and clearance in nonobese healthy men. J Clin Endocrinol Metab,1992,75: 170-175.
  • 8Purrello F, Rabuazza AM. Metabolic factors that affect betacell function and survival. Diabet Nutr Metab, 2000, 13: 84-91.
  • 9Sivitz WI. Lipotoxieity and glueotoxieity in type 2 diabetes. Effects on development and progression. Postgrad Med, 2001,109: 55-59,63-64.
  • 10Lenhard M J, Reeves GD. Continous subcutaneous insulin infusion: a comprehensive review of insulin pump therapy. Arch Intern Med,2001,161: 2293-2300.

共引文献1512

同被引文献27

  • 1吴波,韩萍,刘秀华.胰岛素泵在糖尿病病人围手术期的临床应用[J].中国医科大学学报,2005,34(1):87-88. 被引量:6
  • 2郝振明,雷晋,焦海梅,孟艳斌.糖尿病患者严重烧伤三例[J].中华烧伤杂志,2006,22(1):3-3. 被引量:7
  • 3Weng J, Li Y, Xu W,et al. Effect of intensive insulin therapy on beta -cell function and glycaemic control in patients with newly diag- nosed type 2 diabetes : a multicentre randomised parallel - group trial [ J ]. Lancet,2008,371 (9626) : 1753 - 60.
  • 4Gerstein HC, Riddle MC, Kendall DM, et al. Glycemia treatment strategies in the action to control cardiovascular risk in diabetes (ACCORD) trial[J]. Am J Cardiol,2007,99(12A) :34i -43i.
  • 5Rosenstock J, Schwartz SL, Clark C, et al. Basal insulin therapy in type 2 diabetes :27-week comparison of insulin glarglne ( HOM901 ) and NPH insulin [ J ]. Diabetes Care,2001,24 ( 11 ) :631 - 6.
  • 6Singh SR, Abroad F, Lal A ,et al. Efficacy and safety of insulin analogues for the management of diabetes mellitus: a meta-analysis [J]. CMAJ,2009,180(4) :385 -97.
  • 7Datta S, Qaadir A, Vianueoa G, et M. Once-daily insulin Glargine versus 6-hour sliding scale regular insulin for control of hyperglycemia after a bariatric surgical procedure : a randomized clinical trial[J].Endocr Pract ,2007,3 ( 13 ):225 - 31.
  • 8Gerich J,Beeker RH,Zhu R,et al. Fluctuation of serum basal insulin levels following single and multiple dosing of insulin glargine[J].Diabetes Technol Ther, 2006,8 ( 2 ) : 237 - 43.
  • 9Riddle MC, Rosenstock J, Gerich J. The treal-to-target trial ranaomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetes patients [J]. Diabetes Care,2003,26( 11 ) :3080 -6.
  • 10Kann PH, Washcher T, Zaekova V, et al. Staring insulin therapy in type 2 diabetes:twice-daily biphasic insulin aspart30 plus metformin versus one daily insulin glargine plus glimepiride[ J]. Exp Clin Endocrinol Diabetes,2006,114 ( 9 ) :527.

引证文献5

二级引证文献37

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部